Introduction
============

Osteoporosis (OP) is a chronic and systematic disease characterized by reduced bone mass and destruction of bone microstructure ([@b1-etm-0-0-7003]). In the early stage, although the risk of brittle fractures increase significantly, there is no or little clinical manifestations arousing patient\'s due attention. The present diagnostic standard, bone mineral density (BMD), can not fully reflect the changes in bone strengths. In fact, for BMD standard, patients with fragile fractures were frequently diagnosed above the OP threshold ([@b2-etm-0-0-7003]). Recent studies showed that the reduction of bone strength is often accompanied by an increase amount of bone marrow adipose tissues and decreased bone mass in post-menopausal OP patients ([@b3-etm-0-0-7003]). Furthermore, change of bone microstructure parameters was observed as well ([@b4-etm-0-0-7003]). MRI-based detection of bone marrow adipose tissue was limited to human bone or rabbit models and the combined application of micro-CT and mechanical experiments in OP studies are rare. We hypothesize that adipose tissue contents and bone microstructure correlate with each other and both influence bone strength during the process of OP. This study analyzed the vertebral bone marrow adipose tissue contents and bone microstructure changes in OP rats longitudinally with these two techniques.

Materials and methods
=====================

Forty Sprague-Dawley (SD) female rats (6-month-old) without history of pregnancy were used in this study. The rats were SPF grade and weighed approximately 205±20 g, and were purchased from Shanghai Slack Laboratory Animal Co., under the license of SCXK (Shanghai, China) 2012--0002. The animals were randomly divided into SHAM (20 rats) and OVX group (20 rats). The experimental treatments were in accordance with the guidelines of Ethical Issues in Animal Experimentation, 2009 ([Table I](#tI-etm-0-0-7003){ref-type="table"}). This study was approved by the Animal Ethics Committee of Soochow University Animal Center (Suzhou, China).

Methods
-------

### Castration and SHAM

Forty healthy female Sprague-Dawley rats (6-month-old) were randomly divided into ovariectomized group (OVX, 20 rats) and sham operation group (SHAM, 20 rats). Anesthesia was performed by intraperitoneal injection with 10% chloral hydrate. The OVX group rats were subjected to bilateral ligation and removal of ovaries, while from SHAM group rats with retained ovaries the same quantity of retroperitoneal fat was resected. To prevent surgical infection, penicillin was used routinely. All the rats were subjected to sub-cage feeding, free drinking, eating and free activities.

### Dixon water-fat separation imaging

Prior to MRI dedicated sequences, conventional T1WI and T2WI sequential scan was performed to exclude possible vertebral lesions. MRI examinations were conducted at baseline, 4th, 8th, and 12th weeks after surgery in each five rats from the two groups with the human knee coil. The Dixon scan used the TSE-Dixon technique with the same parameters (TR =2,800.00 msec, TE =96.00 msec, FOV =105×105 mm, layer thickness =2.0 mm, spacing =2.0 mm, 192 × 56, inversion angle =150°, bandwidth =349 Hz/pixel, pixel =0.2 × 0.2 × 2.0 mm, excitation for 3 times and scanning time 6 min). Four dataset images with the synchronized, opposite, fat and water phase were obtained. The fat phase was divided by the synchronized phase image to generate a DIV (divided, DIV) image with workstation software. By combining the generated DIV image and the water phase image as the position one, a hand-drawn region of interest (ROI) was made to estimate the fat fraction (FF), *i.e*. the percentage of fat intensity in the total signal of water-fat mixture. The calculation formula is FF = Sfat / (Sfat + Swater) ×100% (Sfat and Swater represents the total signal intensity of aimed pixel values, individually), marrow FF of the interest region was obtained for each time-point. Each measurement was performed twice by the same investigator and the average value was considered as the final result. Additionally, interested areas containing the maximum inclusion of the entire cancellous bone in the 5th lumbar vertebra were measured, carefully avoiding the surrounding cortex of bones.

### Micro-CT scan

After the MRI examination, the rats were sacrificed in a CO2 chamber and the specimens were sampled for micro-CT scanning. The scanning parameters were as follows: Voltage 50 KV, current 200 mA, interlayer spacing 18 µm, scanning rotation 180°, scanning time 10 min, average frame rate 1, angle gains 0.7° and the exposure time 400 msec. CT values were calibrated with the standard phantom before scanning. Data were imported into workstation and were analyzed with in-house CT analyzer (version 1.10) software. In order to intuitively display the morphological characteristics of each sample, three-dimensional reconstruction was performed by using Mimics 10.01.

### Biomechanical analysis

Samples were thawed under room temperature and were placed on testing machine. By adjusting the pressure head, close to the lumbar vertebral body, the span was set at 1 cm and specimens were made with a speed of 1 mm/min movement. The compression was stopped when the vertebral bodies had a fracture or collapse. The load/deformation curve was automatically depicted with the workstation\'s in-house drawing software. In this experiment, the tested indicators were as follows: Maximum breaking load, failure stress and elastic modulus.

### Statistical analysis

All the experimental data are presented as mean ± standard deviation (SD) and analyzed with t-test by SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Time-course FF variation in MR Dixion

Compared with SHAM group, FF increased with time in the OVX group by 20.8, 42.1 and 62.4% at 4th, 8th and 12th week, respectively. At the 4th, 8th and 12th week, the FF increased by 18.8, 36.0 and 42.4% respectively, when comparing with those in the SHAM group. Overall, the trend was statistically significant from the 4th week ([Fig. 1](#f1-etm-0-0-7003){ref-type="fig"}; [Table II](#tII-etm-0-0-7003){ref-type="table"}).

### Bone morphological analysis through micro-CT

In OVX group, BVF showed a time-course decreasing trend, whereas Tb.Sp and SMI demonstrated an increasing trend. Specifically, Tb.Sp differences between the OVX group and SHAM group occurred at the 4th week, while BVF and SMI occurred at the 8th week. Tb.N did not show significant inter-group or intra-group differences. Moreover, Tb.Th reduced by 19.7% at the 12th week compared with baseline and by 17.9% compared with SHAM group at the same time-point ([Table II](#tII-etm-0-0-7003){ref-type="table"}). Three-dimensional reconstruction showed that the trabecular spaces followed a significant enlargement over time. Furthermore, the trabecular bones were partially broken, perforated and the bone mass significantly reduced ([Fig. 2](#f2-etm-0-0-7003){ref-type="fig"}).

### Biomechanical characteristics

Compared to SHAM group, the OVX group showed inferior maximum breaking load, breaking stress and elastic modulus. In the temporal analysis for OVX rats, there was a statistical difference of elastic modulus at the 4th week from baseline, whereas the maximum failure load and failure stress showed statistical difference at the 8th week ([Table III](#tIII-etm-0-0-7003){ref-type="table"}).

### Bone marrow histology

HE staining showed that the density and diameter of adipocytes tended to increase gradually with time in the OVX group ([Fig. 3](#f3-etm-0-0-7003){ref-type="fig"}).

### Relationship between FF, morphological parameters and biomechanical characteristics

FF was correlated with bone morphological parameters and biomechanical properties in OVX group. Specifically, FF was negatively associated with BVF (r=−0.879, P\<0.01), failure stress (r=−0.833, P\<0.01) and elastic modulus (r=−0.804, P\<0.01), whereas moderately related to maximum failure load (r=−0.716, P\<0.01) and Tb.Th (r=−0.484, P\<0.05). FF was positively correlated with Tb.Sp (r=0.841, P\<0.01) and SMI (r=0.838, P\<0.01). However, there was no significant correlation between FF and Tb. N (r=−0.198, P\>0.05).

Discussion
==========

Currently, BMD is widely used as the 'gold standard' for OP diagnosis. However, due to its low sensitivity and poor specificity, BMD cannot fully reflect the actual changes of bone strength. Previous studies showed that there was a great 'overlap' of BMD between patients with or without brittle fractures ([@b5-etm-0-0-7003]). It is now believed that the changes of bone mass and bone marrow components are the authentic determinant factors of bone fragility, thus, could play as more accurate diagnostic roles independent of BMD ([@b6-etm-0-0-7003]--[@b8-etm-0-0-7003]).

By using X-ray scanning and three-dimensional reconstruction technology, micro-CT techniques abolish the limitations of plane projection. Therefore, thickness of various forms of bone structure can be directly measured which clearly describes the three-dimensional distribution and bone morphological characteristics. Moreover, as the ideal tools for bone morphology study, micro-CT techniques can effectively monitor the dynamic changes of cancellous bone trabecula ([@b9-etm-0-0-7003]). Due to reduced level of estrogen through bilateral ovarian castration, bone morphological characteristics of vertebral bodies notably changed as shown by the two-point Dixon combined with micro-CT analysis. After 8 weeks of castration, bone microstructure parameters, except Tb.N and Tb.Th, significantly changed, which was in accordance with previous studies ([@b10-etm-0-0-7003]). At 4th week, the BVF decreased by 11.9%, whereas the Tb.Sp and SMI increased by 29.0 and 39.6%, respectively in the OVX group. These changes were preceding other parameters. At 12th week, Tb.Th decreased by 19.7% while Tb.N showed a decreasing trend though without statistically significance. The changed levels of Tb.N and Tb.Th could be ascribed to the redistribution of stress point in cancellous bone trabeculae, which were caused by the degeneration of bone microarchitecture as well as losses of bone mass. Therefore, reconstruction of the bone trabeculae could delay the reduced level of Tb.N and Tb.Th. There is a certain correlation between trabecular bone microstructure parameters and the biomechanical test results, such as breaking stress, elastic modulus and the maximum breaking load. In this study, BVF, Tb.Sp and SMI showed the closest relationship to mechanical properties and could be used as effective predictors of fracture risk. Furthermore, the cancellous bone trabeculae thinning, absorption, fracture and even perforation could limit the resistance to normal tensions in OP. Minematsu *et al* ([@b11-etm-0-0-7003]) also verified that the bone morphological parameters were closely related to the mechanical strength of OP bone tissue. In our previous studies, the two-point Dixon water-fat separation technique was proved as a noninvasive monitoring method for changes of bone marrow adipose tissue content in OP process. The changed level of bone marrow adipose tissue was found prior to bone mass lost, that was consistent with the findings of Di Iorgi *et al* ([@b12-etm-0-0-7003]). Additionally, the bone marrow fat content and the morphological parameters showed certain correlation with the biomechanical properties. There was a positive relationship between bone marrow fat content and Tb.Sp/SMI, whereas BVF was negatively correlated. In terms of bone strength, there was a significant negative correlation between FF and the failure stress and elastic modulus, indicating that the increased level of bone marrow adipose tissue could weaken the bone strength and increases the risk of brittle fracture in OP induced by estrogen deficiency. In another case, it showed that bone marrow adipose tissue played an important role in OP development ([@b13-etm-0-0-7003]). Previous studies showed that OP patients were considerably accompanied by an increasing level of bone marrow adipose contents, while alleviated OP lead to decreasing adipose level. Interestingly, diabetes and glucocorticoid-treated patients showed a negative correlation with the level of bone mass, which lead to the speculation that the bone marrow adipose tissue plays a negative role in controlling bone formation ([@b14-etm-0-0-7003]). Here, bone marrow adipose content, morphological parameters and biomechanical properties was verified to be closely associated. At present, mechanisms of increased bone marrow adipose tissue affecting bone strength are still unclear. Typical explanations are as follows: One theory goes that increased level of bone marrow adipose tissue was a compensatory results of trabecular bone thinning in the cancellous bone and the spaces caused by the trabecular gap enlargement ([@b15-etm-0-0-7003]), while a contrary opinion argues that the increased level of bone marrow adipose tissue was not a 'passive' process, but could 'actively' compress the trabecular bone and accelerates the destructive absorption of cancellous bone ([@b4-etm-0-0-7003]). Another theory considering the bone marrow in the marrow cavity, in addition to undertaking hematopoietic functions, play roles in mechanical support and pressure buffering. It is reasonable to note that yellow bone marrow bears good compressibility and shows significant weakness of structural support functioning compared to red bone marrow. Therefore, growth of yellow bone marrow could gradually replace the red bone marrow, which leads to a weakened bone strength after years of aging ([@b16-etm-0-0-7003]). The third theory accounts the fact that osteoblasts and adipocytes in bone marrow both derive from mesenchymal stem cells (MSCs) ([@b17-etm-0-0-7003],[@b18-etm-0-0-7003]). Over-differentiation of adipocytes could inevitably cause poor osteogenics, which lead to an interesting assumption that migration of MSCs into adipogenic cells could be the origin of OP ([@b19-etm-0-0-7003]). Specifically, OP occurs through regulating the expression of peroxisome proliferation-activated receptor (PPARγ) and core-binding factor α1/runt-related transcription factor 2 (Cbfα1/Runx2) ([@b20-etm-0-0-7003]).

In conclusion, increased level of adipose tissue in the bone marrow weakens the bone strength and increases the risk of fragile fractures in OP. FF and bone morphological parameters, being interactive and independent of each other, jointly influence the condition of bone mass. The combined application of the two-point Dixon water-fat separation technology and micro-CT, on the one hand, could three-dimensionally, accurately and intuitively investigate the bone morphology and parameters, on the other hand, could measure the bone structure parameters of OP trabecular and cortical bone. The current methodology provides more accurate qualitative and quantitative data in OP process, which can fully and accurately evaluate related biological characteristics, thus sheding light on in-depth basic and applied OP research.
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![Images of two-point TSE-Dixon MRI of group OVX. (A-D) The TSE-Dixon image of the synchronized phase, the opposite phase, the lipid phase and the aqueous phase. (E-F) The schematic diagram of ROI FF by combining the DIV image (E) and water phase image (F). FF, fat fraction; ROI, region of interest.](etm-17-01-0689-g00){#f1-etm-0-0-7003}

![Three-dimensional reconstruction of vertebral bone through micro-CT for OVX group rats. (A-D) Represents the morphological reconstruction of vertebral bone at baseline, 4th, 8th and 12th weeks in OVX group rats. After 12 weeks, the trabecular gaps significantly expanded, trabecular fracture and perforation was also remarkably increased.](etm-17-01-0689-g01){#f2-etm-0-0-7003}

![HE staining of OVX group. (A-D) The baseline, the 4th week, the 8th week and the 12th week HE image (HE; magnification, ×200).](etm-17-01-0689-g02){#f3-etm-0-0-7003}

###### 

Based on the two-point Dixon water-fat separation, vertebral bone marrow adipose tissue was analyzed in osteoporotic rats. The relevant materials and instruments are listed.

  Materials and instruments   Vendors
  --------------------------- -------------------------------------------------------
  Micro-CT Skyscan1176        Skyscan, Kontich, Belgium
  CT analyzer1.10             Skyscan
  Mimics10.01                 Skyscan
  Magnetom Skyra 3T           Siemens AG, Munich, Germany
  HY-1080                     Hengyi Precision Instrument Co. Ltd., Shanghai, China
  PFA                         Wuxi Zhanwang Chemical Co., Ltd., Wuxi, China

###### 

Time-course profiling of FF and bone morphology.

  Items          Groups   Week 0         Week 4                                                                                                   Week 8                                                                                                                                               Week 12                                                                                                                                               F-value   P-value
  -------------- -------- -------------- -------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------- --------- ---------
  FF, %          SHAM     17.9±2.3       18.1±1.9                                                                                                 18.6±1.5                                                                                                                                             20.3±1.7                                                                                                                                              1.739     0.199
                 OVX      17.8±1.4       21.5±1.8^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"},[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^      25.3±1.6^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"},[b](#tfn2-etm-0-0-7003){ref-type="table-fn"},[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^     28.9±1.7^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"}--[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^                                                  42.466    \<0.001
  BVF, %         SHAM     56.43±2.22     56.35±2.64                                                                                               55.12±3.65                                                                                                                                           53.49±3.28                                                                                                                                            1.050     0.397
                 OVX      55.57±2.87     48.93±3.47^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"}^                                                 39.42±3.32^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"},[b](#tfn2-etm-0-0-7003){ref-type="table-fn"},[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^   31.41±2.98^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"}--[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^                                                55.903    \<0.001
  Tb.N, mm^−1^   SHAM     4.82±0.33      4.71±0.27                                                                                                4.65±0.29                                                                                                                                            4.56±0.37                                                                                                                                             0.604     0.622
                 OVX      4.78±0.26      4.67±0.31                                                                                                4.73±0.27                                                                                                                                            4.51±0.36                                                                                                                                             0.789     0.517
  Tb.Th, µm      SHAM     119.73±9.99    119.62±10.12                                                                                             118.24±13.50                                                                                                                                         117.50±13.98                                                                                                                                          0.041     0.989
                 OVX      120.10±12.83   113.38±10.53                                                                                             107.32±12.10                                                                                                                                         96.45±11.21^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"},[b](#tfn2-etm-0-0-7003){ref-type="table-fn"},[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^   3.683     0.034
  Tb.Sp, mm      SHAM     92.53±14.73    93.12±10.08                                                                                              93.08±8.85                                                                                                                                           95.12±8.14                                                                                                                                            0.056     0.982
                 OVX      91.39±13.10    117.92±8.41^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"},[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^   133.41±14.90^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"},[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^                                              159.47±10.75^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"}--[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^                                              28.015    \<0.001
  SMI            SHAM     0.59±0.08      0.61±0.16                                                                                                0.65±0.12                                                                                                                                            0.67±0.15                                                                                                                                             0.367     0.778
                 OVX      0.53±0.09      0.74±0.13^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"}^                                                  1.09±0.19^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"},[b](#tfn2-etm-0-0-7003){ref-type="table-fn"},[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^    1.42±0.17^[a](#tfn1-etm-0-0-7003){ref-type="table-fn"}--[d](#tfn4-etm-0-0-7003){ref-type="table-fn"}^                                                 34.150    \<0.001

P\<0.05, statistical difference compared to week 0

P\<0.05, statistical difference compared to week 4

P\<0.05, statistical difference compared to week 8

P\<0.05, statistical difference between the OVX group and the SHAM group; FF, fat fraction.

###### 

Time-course profiling of biomechanical characteristics after ovariectomized treatment.

  Items                  Groups   Week 0       Week 4                                                                                                  Week 8                                                                                                                                               Week 12                                                                                                                                              F-value   P-value
  ---------------------- -------- ------------ ------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- --------- ---------
  Break load, N          SHAM     215.3±26.8   207.3±29.3                                                                                              201.8±31.1                                                                                                                                           194.7±32.8                                                                                                                                           0.419     0.742
                         OVX      209.7±26.2   182.3±28.4                                                                                              150.3±33.0^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[d](#tfn8-etm-0-0-7003){ref-type="table-fn"}^                                                110.3±45.3^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[b](#tfn6-etm-0-0-7003){ref-type="table-fn"},[d](#tfn8-etm-0-0-7003){ref-type="table-fn"}^   7.899     0.002
  Break stress, MPa      SHAM     23.3±2.9     22.3±3.8                                                                                                21.6±3.6                                                                                                                                             20.8±3.5                                                                                                                                             0.465     0.711
                         OVX      22.6±2.5     19.7±3.0                                                                                                16.1±2.5^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[d](#tfn8-etm-0-0-7003){ref-type="table-fn"}^                                                  11.9±3.2^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"}--[d](#tfn8-etm-0-0-7003){ref-type="table-fn"}^                                                 13.760    \<0.001
  Elastic modulus, MPa   SHAM     476.2±25.1   480.8±39.3                                                                                              532.4±29.8^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[b](#tfn6-etm-0-0-7003){ref-type="table-fn"}^                                                551.3±30.0^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[b](#tfn6-etm-0-0-7003){ref-type="table-fn"}^                                                7.076     0.003
                         OVX      482.4±25.7   364.8±45.6^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[d](#tfn8-etm-0-0-7003){ref-type="table-fn"}^   291.4±35.0^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[b](#tfn6-etm-0-0-7003){ref-type="table-fn"},[d](#tfn8-etm-0-0-7003){ref-type="table-fn"}^   263.9±43.2^[a](#tfn5-etm-0-0-7003){ref-type="table-fn"},[b](#tfn6-etm-0-0-7003){ref-type="table-fn"},[d](#tfn8-etm-0-0-7003){ref-type="table-fn"}^   32.771    \<0.001

P\<0.05, statistical difference compared to week 0

P\<0.05, statistical difference compared to week 4

P\<0.05, statistical difference compared to week 8

P\<0.05, statistical difference between the OVX group and the SHAM group.
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